Detalle de: Pharmacogenomics and Tumor Biomarkers
| Title | Pharmacogenomics and Tumor Biomarkers |
| Description |
The main interest of the Pharmacogenomics and Tumor Biomarkers Group is understanding how genomic variation modifies drug treatment response, with the ultimate goal of using this knowledge to design more specific drug treatments. In cancer, drug therapy failure is a major clinical problem and developing safer and more effective anticancer drug treatment strategies is urgently needed. Our top priority is improving the survival and quality of life of cancer patients. |
| Home Page | https://www.csic.es/en/investigation/research-groups/pharmacogenomics-and-tumor-biomarkers |
| Contact Email | crodriguezan@iib.uam.es |
| Collaborating Companies | |
| Spin Off | |
| Patents | |
| Hpc Resources | |
| Institution | IIBM |
| Ontology | |
| Tools | |
| Service Units | |
| Research Lines | Pharmacogenomics of anticancer drug response, Tumor biomarkers for cancer therapy |
| Funded Projects | |
| Selected Publications |
|
| Researchers | Alicia Arenas Cortés |